ZyVersa Therapeutics (ZVSA) Misses Q2 EPS by 46c
Tweet
Share
E-mailGet Alerts ZVSA Hot Sheet
Join SI Premium – FREE
ZyVersa Therapeutics (NASDAQ: ZVSA) reported Q2 EPS of ($0.46).
For earnings history and earnings-related data on ZyVersa Therapeutics (ZVSA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Anthropic Signs $35b Cloud Deal With Lambda In Texas: WSJ
- Air Conditioning Company in South Florida, Peachy Keen Air Conditioning, Plumbing, Heating, Launches Safety Initiative
- Lobe Sciences closes $2.16M private placement for S-100 drug program
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
